NCT03814759View on ClinicalTrials.gov

Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

July 31, 2022

Conditions
Gastric Adenocarcinoma
Interventions
DRUG

TS-1 + cisplatin

S-1 20mg/m2, bid (D1\~14, D22\~35) Cisplatin 30mg/m2/day (W1, 2, 4, 5)

RADIATION

radiation

radiation 45Gy per 5 weeks

Trial Locations (1)

03722

Severance Hospital, Yonsei University Health System, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03814759 - Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter